Abstract
Children with sickle cell disease (SCD) experience disproportionately high rates of psychological problems. Our goal was to examine the clinical utility of psychological screening measures to identify children with such problems in medical settings. Caregivers completed screening measures assessing social–emotional problems, ADHD symptoms, executive dysfunction, and health-related quality of life for children with SCD (receiving either chronic blood transfusion or hydroxyurea) and their siblings. Our findings demonstrated that screening measures identified clinically elevated symptoms in children with SCD that had not been previously reported. Scores for siblings were for the most part in the normal range. The number of days hospitalized (but not cerebral infarct status) predicted higher scores, emphasizing the challenges associated with SCD complications. Overall, our findings support the notion that screening measures reduce the need for reliance on medical provider judgment for psychological referrals and increase equitability in access to services. Early identification resulting in early intervention has contributed substantially to improved psychological functioning in many contexts, and it is thus likely that such improvements would also be achieved in this uniquely vulnerable population.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10880-019-09654-y/MediaObjects/10880_2019_9654_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10880-019-09654-y/MediaObjects/10880_2019_9654_Fig2_HTML.png)
Similar content being viewed by others
References
Acquazzino, M. A., Miller, M., Myrvik, M., Newby, R., & Scott, J. P. (2017). Attention deficit hyperactivity disorder in children with sickle cell disease referred for an evaluation. Journal of Pediatric Hematology/oncology, 39, 350–354.
Anie, K. A. (2005). Psychological complications in sickle cell disease. British Journal of Haematology, 129, 723–729.
Ashley-Koch, A., Murphy, C. C., Khoury, M. J., & Boyle, C. A. (2001). Contribution of sickle cell disease to the occurrence of developmental disabilities: A population-based study. Genetics in Medicine, 3, 181.
Badawy, S. M., Thompson, A. A., Penedo, F. J., Lai, J., Rychlik, K., & Liem, R. I. (2017). Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease. European Journal of Haematology, 98, 608–614.
Barbarin, O. A., Whitten, C. F., & Bonds, S. M. (1994). Estimating rates of psychosocial problems in urban and poor children with sickle cell anemia. Health and Social Work, 19, 112–119.
Bennett, S., Shafran, R., Coughtrey, A., Walker, S., & Heyman, I. (2015). Psychological interventions for mental health disorders in children with chronic physical illness: A systematic review. Archives of Disease in Childhood, 100, 308–316.
Benton, T. D., Boyd, R., Ifeagwu, J., Feldtmose, E., & Smith-Whitley, K. (2011). Psychiatric diagnosis in adolescents with sickle cell disease: A preliminary report. Current Psychiatry Reports, 13, 111–115.
Benton, T. D., Ifeagwu, J. A., & Smith-Whitley, K. (2007). Anxiety and depression in children and adolescents with sickle cell disease. Current Psychiatry Reports, 9, 114–121.
Berg, C., Edwards, D. F., & King, A. (2012). Executive function performance on the children’s kitchen task assessment with children with sickle cell disease and matched controls. Child Neuropsychology, 18, 432–448.
Berkelhammer, L. D., Williamson, A. L., Sanford, S. D., Dirksen, C. L., Sharp, W. G., Margulies, A. S., & Prengler, R. A. (2007). Neurocognitive sequelae of pediatric sickle cell disease: A review of the literature. Child Neuropsychology, 13, 120–131.
Beverung, L. M., Varni, J. W., & Panepinto, J. A. (2015). Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease. Journal of Pediatric Hematology/oncology, 37, 128.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. New York: Lawrence Erlbaum.
Conners, C. K., Pitkanen, J., & Rzepa, S. R. (2011). Conners comprehensive behavior rating scale. New York: Springer.
Croghan, T. W., & Brown, J. D. (2010). Integrating mental health treatment into the patient centered medical home. MD: Agency for Healthcare Research and Quality Rockville.
Dampier, C., Jaeger, B., Gross, H. E., Barry, V., Edwards, L., Lui, Y., … Reeve, B. B. (2016). Responsiveness of PROMIS® pediatric measures to hospitalizations for sickle pain and subsequent recovery. Pediatric Blood & Cancer, 63, 1038–1045.
Dampier, C., Lieff, S., LeBeau, P., Rhee, S., McMurray, M., Rogers, Z., … Wang, W. (2010). Health-related quality of life in children with sickle cell disease: A report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium. Pediatric Blood & Cancer, 55, 485–494.
DeBaun, M. R., & Kirkham, F. J. (2016). Central nervous system complications and management in sickle cell disease: A review. Blood, 127, 829–838.
Gioia, G. A., Isquith, P. K., Guy, S. C., & Kenworthy, L. (2015). BRIEF-2: Behavior rating inventory of executive function. Psychological Assessment Resources.
Hilliard, L. M., Kulkarni, V., Sen, B., Caldwell, C., Bemrich-Stolz, C., Howard, T. H., … Lebensburger, J. D. (2018). Red blood cell transfusion therapy for sickle cell patients with frequent painful events. Pediatric Blood & Cancer, 65, e27423.
Hood, A. M., King, A. A., Fields, M. E., Ford, A. L., Guilliams, K. P., Hulbert, M. L., … White, D. A. (2019). Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease. Pediatric Blood & Cancer, 0(0), e27899. https://doi.org/10.1002/pbc.27899.
Ivascu, N. S., Sarnaik, S., McCrae, J., Whitten-Shurney, W., Thomas, R., & Bond, S. (2001). Characterization of pica prevalence among patients with sickle cell disease. Archives of Pediatrics and Adolescent Medicine, 155, 1243–1247.
Jerrell, J. M., Tripathi, A., & McIntyre, R. S. (2011). Prevalence and treatment of depression in children and adolescents with sickle cell disease: A retrospective cohort study. The Primary Care Companion to CNS Disorders, 13, 14.
Jonassaint, C. R., Jones, V. L., Leong, S., & Frierson, G. M. (2016). A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. British Journal of Haematology, 174, 136–147.
Lance, E. I., Comi, A. M., Johnston, M. V., Casella, J. F., & Shapiro, B. K. (2015). Risk factors for attention and behavioral issues in pediatric sickle cell disease. Clinical Pediatrics, 54, 1087–1093.
Liu, S.-I., Lu, R.-B., & Lee, M.-B. (2008). Non-psychiatric physicians’ knowledge, attitudes and behavior toward depression. Journal of the Formosan Medical Association, 107, 921–931.
Ludwig, N. N., Sil, S., Khowaja, M. K., Cohen, L. L., & Dampier, C. (2018). Executive functioning mediates the relationship between pain coping and quality of life in youth with sickle cell disease. Journal of Pediatric Psychology, 43, 1160–1169.
Lukoo, R. N., Ngiyulu, R. M., Mananga, G. L., Gini-Ehungu, J.-L., Ekulu, P. M., Tshibassu, P. M., & Aloni, M. N. (2015). Depression in children suffering from sickle cell anemia. Journal of Pediatric Hematology/oncology, 37, 20–24.
Myrvik, M. P., Burks, L. M., Hoffman, R. G., Dasgupta, M., & Panepinto, J. A. (2013). Mental health disorders influence admission rates for pain in children with sickle cell disease. Pediatric Blood & Cancer, 60, 1211–1214.
Ojelabi, A., Graham, Y., & Ling, J. (2017). Health-related quality of life predictors in children and adolescents with sickle cell disease: A systematic review. International Journal of Tropical Disease & Health, 22, 1–14. https://doi.org/10.9734/IJTDH/2017/31954.
Olson, A. L., Kelleher, K. J., Kemper, K. J., Zuckerman, B. S., Hammond, C. S., & Dietrich, A. J. (2001). Primary care pediatricians’ roles and perceived responsibilities in the identification and management of depression in children and adolescents. Ambulatory Pediatrics, 1, 91–98.
Panepinto, J. A., O’Mahar, K. M., DeBaun, M. R., Rennie, K. M., & Scott, J. P. (2004). Validity of the child health questionnaire for use in children with sickle cell disease. Journal of Pediatric Hematology/oncology, 26, 574–578.
Panepinto, J. A., Torres, S., Bendo, C. B., McCavit, T. L., Dinu, B., Sherman-Bien, S., … Varni, J. W. (2013). PedsQL™ sickle cell disease module: Feasibility, reliability, and validity. Pediatric Blood & Cancer, 60, 1338–1344.
Prussien, K. V., Jordan, L. C., DeBaun, M. R., & Compas, B. E. (2019). Cognitive function in sickle cell disease across domains, cerebral infarct status, and the lifespan: A meta-analysis. Journal of Pediatric Psychology. https://doi.org/10.1093/jpepsy/jsz031.
R Core Team. (2017). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
Redding-Lallinger, R., & Knoll, C. (2006). Sickle cell disease: Pathophysiology and treatment. Current Problems in Pediatric and Adolescent Health Care, 36, 346–376.
Reed-Knight, B., Thompson, B., Bigham, L., Sil, S., Griffin, A., & Johnson, A. (2015). Identification of pica behaviors in youth with sickle cell disease: A quality improvement (QI) project. Clinical Practice in Pediatric Psychology, 3, 167.
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010). Sickle-cell disease. The Lancet, 376, 2018–2031.
Reynolds, C. R., & Kamphaus, R. W. (2015). BASC-3 behavioral and emotional screening system manual. Circle Pines: Pearson.
Schatz, J., Finke, R. L., Kellett, J. M., & Kramer, J. H. (2002). Cognitive functioning in children with sickle cell disease: A meta-analysis. Journal of Pediatric Psychology, 27, 739–748.
Schlenz, A. M., Schatz, J., McClellan, C. B., & Roberts, C. W. (2012). Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease. Journal of Pediatric Psychology, 37, 798–807.
Schwartz, L. A., Radcliffe, J., & Barakat, L. P. (2009). Associates of school absenteeism in adolescents with sickle cell disease. Pediatric Blood & Cancer, 52, 92–96.
Unützer, J., & Park, M. (2012). Strategies to improve the management of depression in primary care. Primary Care: Clinics in Office Practice, 39, 415–431.
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017). Sickle cell disease. The Lancet, 390, 311–323.
Williams, J., Klinepeter, K., Palmes, G., Pulley, A., & Foy, J. M. (2004). Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics, 114, 601–606.
Acknowledgements
We would like to thank the participants and families who participated in our research for their contributions. We would like to acknowledge Maggie Clapp, Amanda Namchuk, and Neeti Shenoy for their contributions to data collection and study management, as well as the physicians and staff of St. Louis Children’s Hospital who generously contributed to the study through recruitment. This research was supported in part by the National Heart, Lung, and Blood Institute (1F31HL134314, and 1U01HL133994). Research was also supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number U54 HD087011 to the Intellectual and Developmental Disabilities Research Center at Washington University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Anna M. Hood, Ilana Reife, Allison A. King, and Desiree A. White declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
The procedures followed for this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). All persons gave their informed consent prior to their inclusion in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hood, A.M., Reife, I., King, A.A. et al. Brief Screening Measures Identify Risk for Psychological Difficulties Among Children with Sickle Cell Disease. J Clin Psychol Med Settings 27, 651–661 (2020). https://doi.org/10.1007/s10880-019-09654-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10880-019-09654-y